412
Views
0
CrossRef citations to date
0
Altmetric
HEMOSTASIS AND THROMBOSIS

Platelet count and serum thrombopoietin level as predictors for morbidity and/or mortality in thrombocytopenic neonates

, , , , &
Pages 341-345 | Published online: 18 Jul 2013

References

  • Forestier F, Daffos F, Catherine N, Renard M, Andreux JP. Developmental hematopoiesis in normal human fetal blood. Blood. 1991;77:2360–3.
  • Castle V, Andrew M, Kelton J, Giron D, Johnston M, Carter C. Frequency and mechanism of neonatal thrombocytopenia. J Pediatr. 1986;108:749–55.
  • Andrew M, Castle V, Saigal S. Clinical impact of neonatal thrombocytopenia. J Pediatr. 1987;110:457–64.
  • Lanzkowsky P. Disorders of platelets in: Lankzkowsky P (ed). Manual of pediatric hematology and oncology. 2nd ed. New York: Churchill Livingstone, 1995.
  • De Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by thr c-MpL ligand. Nature. 1994;369:533.
  • Lok S, Kaushansky K, Holly RD, Kuijper JL, Lofton-Day CE, Oort PJ, et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 1994;369:565.
  • Emmons RV, Reid DM, Cohen RL, Meng G, Young NS, Dunbar CE, et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood. 1996;87:4068–71.
  • Murray NA, Roberts IA. Circulating megakaryocytes and their progenitors (BFU-MK and CFU-MK) in term and preterm neonates. Br J Haematol. 1995;89:41–6.
  • Nishihira H, Toyoda Y, Miyazaki H, Kigasawa H, Ohsaki E. Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c-MpL ligand) and the effects of gestational age on frequency of colonies. Br J Haematol. 1996;92:23–8.
  • Murray NA, Watts IL, Roberts IA. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res. 1998;43:148–51.
  • Roberts IA, Murray NA. Neonatal thrombocytopenia: new insights into pathogenesis and implications for clinical management. Curr Opin Pediatr. 2001;13:16–21.
  • Albert LSE, Meng YC, Lams P. Thrombopoietin in thrombocytopenic term and preterm newborn. Pediatrics. 2000;105:1286–91.
  • Sola MC, Calhoun DA, Hutson AD, Christensen RD. Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic neonates in a neonatal intensive care unit. Br J Haematol. 1999;104:90–2.
  • Folman CC, Linthorst GE, van Mourik J, van Willigen G, de Jonge E, Levi M, et al. Platelet release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis. Thromb Haemos. 2000;3(6):923–30.
  • Walka MM, Sonntag J, Dudenhausen JW, Obladen M. Thrombopoietin concentration in umbilical cord blood of healthy term newborn is higher than adult controls. Biol Neonate. 1999;75:54–8.
  • Colarizi P, Fiorucci P, Caradonna A, Ficuccilli F, Mancuso M, Papoff P. Circulating thrombopoietin levels in neonates with infection. Acta Paediatr. 1999;88:332–7.
  • Fielder PJ, Gurney AL, Stefanich E, Marian M, Moore MW, Carver-More K, et al. Regulation of thrombopoietin level by c-MpL mediated binding to platelet. Blood. 1996;87:2154–61.
  • Sainio S, Javela K, Kekomäki R, Teramo K. Thrombopoietin levels in cord blood plasma and amniotic fluid in fetuses with alloimmune thrombocytopenia and healthy control. Br J Haematol. 2000;109:330–5.
  • Scheding S, Bergmann M, Shimosaka A, Wolff P, Driessen C, Rathke G, et al. Human plasma thrombopoietin levels are regulated by binding to platelet thrombopoietin receptors in vivo. Transfusion. 2002;42:321–7.
  • Liang DC, Shih LY, Chai IJ, Su HT, Liu HC, Shimosaka A. The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of premature neonates. Pediatr Hematolo Oncol. 2002;19(6):399–405.
  • Wolber EM, Fandrey J, Frackowski U, Jelkmann W. Hepatic thrombopoietin mRNA is increased in acute inflammation. Thromb Haemos. 2001;86:142–4.
  • Murray NA, Watts IL, Roberts IA. Thrombopoietin in the fetus and neonate. J Early Hum Dev. 2000;59:1–12.
  • Ikeno K, Koike K, Takeshita A, Shinjo K, Higuchi T, Nakabayashi T, et al. Stressful delivery influences circulating thrombopoietin (Tpo) levels in newborns: possible role for cortisol in Top-Mpl binding. J Haematol. 1999;106:345–56.
  • Oygür N, Tunga M, Mumcu Y, Yeşilipek A, Güra A, Coşkun M, et al. Thrombopoietin levels of thrombocytopenic term and preterm newborns with infection. Am J Perinatol. 2001;18(5):279–86.
  • Hiett AK, Britton KA, Hague NL, Brown HL, Stehman FB, Broxmeyer HE. Comparison of hematopoietic progenitor cells in human umbilical cord blood collected from neonatal infants who are small and appropriate for gestational age. Transfusion. 1995;35:587–91.
  • Sola MC, Du Y, Hutson DA Dose-response relationship of megakaryocyte progenitor from bone marrow and peripheral blood of thrombocytopenic neonates to recombinant thrombopoietin. Pediatr Res. 1999;5:153A.
  • Talaat NR. A study of thrombopoietin in the asphyxiated thrombocytopenic term & preterm newborn [MD thesis]. Cairo University, Cairo, Egypt; 2003.
  • Aly H, El Beshlawy A, Badrawi N, Mohsen L, Mansour E, Ramy N, et al. Thrombopoietin level is increased in the serum of asphyxiated neonates: a prospective controlled study. J Perinatol. 2005;25(5):320–4.
  • Kline A. Thrombopoietin levels following platelet transfusion in neonates with thrombocytopenia. 2008. Available from: http://clinicaltrialsfeeds.org/clinical.
  • Jilma-Stohlawetz P, Folman CC, von dem Borne AE, Pernerstorfer T, Hollenstein U, Knechtelsdorfer M, et al. Effect of anticoagulation on thrombopoietin release during endotoxemia. J Lab Clin Med 1. 2001;37:64–9.
  • Murray NA, Roberts AG. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res. 1996;40:112–9.
  • Meng YG, Martin TG, Peterson ML, Shuman MA, Cohen RL, Wong WL. Circulating thrombopoietin concentrations in thrombocytopenic patients including cancer patients following chemotherapy, with or without peripheral blood progenitor cell transplantation. Br J Haematol. 1996;95:535–41.
  • Vadhan-Raj S, Cohen V, Bueso-Ramos C. Thrombopoietic growth factors and cytokines. Curr Hematol Rep. 2005;4(2):137–44.
  • Kline A, Mackley A, Taylor SM, McKenzie SE, Paul DA. Thrombopoietin following transfusion of platelets in preterm. Platelets. 2008;19(6):428–31.
  • Julian MJ, Daphne W, Yanli D, Joanne U, Valerie K, David C, et al. Phase 1 clinical study of eltrombopag, an oral, non-peptide thrombopoietin receptor agonist. Blood. 2007;109:4739–41.
  • Kuter DJ. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu Rev Med. 2009;60:193–206.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.